This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Cancer Research Technology Limited, Merck Patent Gmbh. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ijmuiden, NL (2017)
- Ljmuiden, NL (2018)
Company Filing History:
2 out of 268 
2 out of 3,022 
Years Active: 2017-2018
Title: Dennis Waalboer: Innovator in Pharmaceutical Compounds
Introduction
Dennis Waalboer is a notable inventor based in Ljmuiden, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of hyperproliferative diseases.
Latest Patents
Waalboer holds 2 patents that showcase his innovative work. His first patent involves novel substituted pyridyl piperidine compounds, which are designed for the treatment of hyperproliferative diseases such as cancer, as well as inflammatory or degenerative diseases. The second patent focuses on 2-aminopyridine compounds, also aimed at treating similar health conditions.
Career Highlights
Throughout his career, Waalboer has worked with prominent organizations, including Cancer Research Technology Limited and Merck Patent GmbH. His experience in these companies has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Waalboer has collaborated with notable professionals in his field, including Kai Schiemann and Frank Stieber. These partnerships have further enhanced his work and innovation in pharmaceutical compounds.
Conclusion
Dennis Waalboer is a distinguished inventor whose work in developing novel pharmaceutical compounds has the potential to impact the treatment of serious diseases. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile